174311-79-6

Basic information

• Product Name: 1H-Indole-7-carboxylicacid,6-amino-,ethylester(9CI)
• Synonyms: 1H-Indole-7-carboxylicacid,6-amino-,ethylester(9CI);Ethyl 6-amino-1H-indole-7-carboxylate;1H-Indole-7-carboxylic acid, 6-aMino-, ethyl ester
• CAS NO: 174311-79-6
• Molecular Formula: C11H12N2O2
• Molecular Weight: 204.23
• Product Categories: AMINOACID
• Mol File: 174311-79-6.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 400.122oC at 760 mmHg
• Flash Point: 195.787oC
• Appearance: /
• Density: 1.288g/cm3
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.669
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• CAS DataBase Reference: 1H-Indole-7-carboxylicacid,6-amino-,ethylester(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Indole-7-carboxylicacid,6-amino-,ethylester(9CI)(174311-79-6)
• EPA Substance Registry System: 1H-Indole-7-carboxylicacid,6-amino-,ethylester(9CI)(174311-79-6)

Safety Data

• Hazardous Substances Data: 174311-79-6(Hazardous Substances Data)

Usage

General Description

1H-Indole-7-carboxylic acid, 6-amino-, ethyl ester (9CI) is a chemical compound belonging to the class of organic compounds known as indoles, which are aromatic heterocyclic compounds with a bicyclic structure. This specific compound features an ethyl ester functional group, which suggests that it is derived from the condensation of an acid (in this case, 1H-Indole-7-carboxylic acid) and an alcohol (in this case, ethanol), and a 6-amino modification on its core indole structure. The "1H" in its name indicates the presence of a hydrogen atom, while "7-carboxylic acid" indicates the presence of a carboxylic acid group at the 7th position in the indole ring. The "9CI" designation implies that this substance is listed in the ninth collective index, suggesting it is a synthetic, rather than naturally occurring, compound. However, the uses and characteristics of this particular compound are not widely documented in existing chemical literature.

InChI:InChI=1/C11H12N2O2/c1-2-15-11(14)9-8(12)4-3-7-5-6-13-10(7)9/h3-6,13H,2,12H2,1H3

Upstream product

• 99-04-7 m-Toluic acid 
• 174311-78-5 (E)-3-<2-(dimethylamino)ethenyl>-2,6-dinitrobenzoic acid ethyl ester 
• 3478-09-9 3-methyl-2,6-dinitrobenzoic acid 
• 90001-60-8 2,6-Dinitro-3-methyl-benzoylchlorid 
• 873055-34-6 3-(2-dimethylamino-vinyl)-2,6-dinitro-benzoic acid ethyl ester 
• 103041-13-0 3-methyl-2,6-dinitrobenzoic acid ethyl ester 
• 54064-40-3 5-methyl-2-nitrobenzoic acid ethyl ester 
• 3113-72-2 5-methyl-2-nitrobenzoic acid 

Relevant articles and documents

Compositions for Treatment of Cystic Fibrosis and Other Chronic Diseases

The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.

COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS AND OTHER CHRONIC DISEASES

The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.

Concise syntheses of the novel 1H-pyrrolo[3,2-g]quinazoline ring system and its [2,3-f] angular isomer

-